Home » Topics » BioWorld Science

BioWorld Science
RSS

LG Chemical licenses thrombin inhibitor to Warner-Lambert

Sep. 15, 1997

NC-1800 now in phase II development

Sep. 15, 1997

Oncologic Drugs Advisory Committee meets this week

Sep. 15, 1997

Biomira reports phase II results for cancer vaccine

Sep. 15, 1997

Preclinical studies show broad antiseizure properties of ganaxolone

Sep. 15, 1997

Matrix discontinues U.S. development of AccuSite

Sep. 15, 1997

SciClone issued European patent for use of thymosin alpha 1 for hepatitis C

Sep. 15, 1997

SDZ-MRL-953 prevents sepsis in cancer patients

Sep. 15, 1997

Preclinical profile of Ono-1101 published

Sep. 15, 1997

Synthetic retinoids with anticoagulant effects

Sep. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...